Navigation Links
Fertility issues in young women with breast cancer must be addressed
Date:3/24/2010

This release is available in Spanish.

Barcelona, Spain: At a time when more and more young women are surviving breast cancer and delaying childbirth, it is important to take their needs and wishes about their future fertility into consideration when deciding on treatment, the seventh European Breast Cancer Conference (EBCC7) in Barcelona will hear today (Wednesday). Dr. Anne Armstrong, from the Department of Medical Oncology, the Christie NHS Foundation Trust, Manchester, UK, will say that, although survival remains the most important priority for most women, many are also concerned about being able to make choices concerning their fertility and potential to become pregnant.

The use of chemotherapy and hormonal treatments in young women can have significant implications for their fertility. Such treatments can stop the ovaries producing eggs, sometimes temporarily but also permanently, thus leading to an early menopause. Options to preserve fertility include freezing eggs or embryos, and also freezing ovarian tissue for transplant at a later date, although this is a new, and to date, little-used technique.

Because of rising breast cancer survival rates and the trend to delay pregnancy until later in life, childless women increasingly experience fertility dilemmas. Dr. Armstrong and her team decided to investigate women's responses to being told that treatments affected their fertility, as well as their attitudes to fertility options.

Twenty-four women who were under 40 at diagnosis with early-stage breast cancer participated in three focus groups. Seven of them had attended specialist fertility services. The researchers found that fertility was a significant issue for many of them. "Many of them had concerns about the implications on breast cancer survival of fertility preservation, changes to treatment to improve fertility, and also pregnancy after breast cancer," says Dr. Armstrong. "They were also concerned that egg harvesting might carry risks to their survival. We found that many of them were getting conflicting advice from health professionals, and this led to increased anxiety and confusion."

The small number of women who had attended specialist fertility services were better informed of their options and of the potential risks of fertility-preserving treatment, and this appeared to be a positive experience which helped them to cope better with the issues, the researchers say. They are now planning to undertake a larger study of both patients and health professionals based on a questionnaire to explore the issues more fully.

"We hope that this will enable us to understand patients' needs better and enable us to develop services which will meet those needs effectively," says Dr. Armstrong. "At a time when breast cancer treatments are improving and allowing more women to live normal lives, it is only right that we should also be helping them, where possible, to take control of their fertility, and informing them about the opportunities to have children should they so desire."


'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
ECCO-the European CanCer Organisation
Source:Eurekalert

Related medicine news :

1. Male Infertility Significantly Increases Risk of Prostate Cancer
2. Infertility Raises Risk of More Aggressive Prostate Cancer
3. Infertility increases a mans risk of prostate cancer
4. Exposure to BPA may cause permanent fertility defects, Yale researchers find
5. OvaCue Fertility Monitor Breakthrough Allows Women to See Fertility Color-coded on a Calendar Over Time
6. Leading U.S. Infertility Practice Opens Boston IVF The Maine Center in Portland, Helping Build Families in Maine
7. Doctors miss major cause of infertility and obesity
8. New Survey Finds Infertility Delivers a Serious Blow to Self-Esteem
9. Fertility drugs contribute heavily to multiple births
10. Fertility Drugs Contribute Heavily to Multiple Births
11. Research suggests link between infertility, low egg reserve, and breast/ovarian cancer gene (BRCA1)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Texas (PRWEB) , ... February 09, 2016 , ... ... reconstruction firm helping businesses recover after a disaster, announced today the acquisition of ... companies in Hawaii. , “Investing in like-minded companies who excel at ...
(Date:2/9/2016)... ... February 09, 2016 , ... Cirracore ... help enterprises move workloads to the cloud. Cirracore provides a secure VMware® ... without traversing the Internet. Transformation Solutions (TSL Partners) provides a full range ...
(Date:2/9/2016)... ... February 09, 2016 , ... On January 12, 2016 Paul ... appointment after they noticed their furnace not producing any heat. Shortly after entering the ... cracked heat exchanger was leaking dangerous levels of carbon monoxide into the home, at ...
(Date:2/9/2016)... California (PRWEB) , ... February 09, 2016 , ... ... of their new nationwide service to expand access to affordable hearing aids ... million hard of hearing individuals in the United States. , “For the average ...
(Date:2/9/2016)... ... February 09, 2016 , ... United ... In Praise of Prevention,” an animated video designed to prevent the ... translations of the video are being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 - ... the North America continued to lead global ... translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... anti-bacterial market is inclined towards North America ...
(Date:2/8/2016)... -- Respiratory Devices - Medical Devices Pipeline Assessment, ... report, " Respiratory Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. The report ... comparative analysis of the products at various stages ... in the pipeline product development. It also provides ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology: